We are live on
!
Find out more
EWA
Evolution Wealth Advisors Portfolio holdings
AUM
$981M
1-Year Est. Return
21.2%
This Fund
S&P 500
This Quarter
Est. Return
+3.12%
1 Year Est. Return
+21.2%
3 Year Est. Return
+66.36%
5 Year Est. Return
+44.78%
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$13.9M
(+6.4%)
Cap. Flow
+$936K
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
74.73%
Holding
495
New
390
Increased
42
Reduced
20
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$20.6M |
| 2 |
Freeport-McMoran
FCX
|
+$10.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.19M |
| 4 |
Alibaba
BABA
|
+$4.8M |
| 5 |
Citigroup
C
|
+$4.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Value ETF
VTV
|
+$11.7M |
| 2 |
SPDR Gold Trust
GLD
|
+$8.91M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$8.37M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$7.04M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.84% |
| 2 | Materials | 5.28% |
| 3 | Consumer Discretionary | 4.18% |
| 4 | Technology | 2.03% |
| 5 | Communication Services | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
126
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21K | 0.01% |
+201
| New | +$15.6K |
|
127
McDonald's
MCD
$188B
| $20K | 0.01% |
+95
| New | +$18.8K |
|
128
Teladoc Health
TDOC
$1.75B
| $20K | 0.01% |
+308
| New | +$18K |
|
129
Teck Resources
TECK
$27.8B
| $20K | 0.01% |
+880
| New | +$19.7K |
|
130
Texas Instruments
TXN
$265B
| $20K | 0.01% |
+173
| New | +$19.3K |
|
131
Adobe
ADBE
$90.3B
| $19K | 0.01% |
+63
| New | +$17.5K |
|
132
Medtronic
MDT
$105B
| $19K | 0.01% |
+196
| New | +$17.9K |
|
133
Union Pacific
UNP
$174B
| $19K | 0.01% |
+110
| New | +$18.9K |
|
134
Jazz Pharmaceuticals
JAZZ
$16B
| $18K | 0.01% |
+125
| New | +$16.8K |
|
135
Coca-Cola
KO
$353B
| $18K | 0.01% |
+344
| New | +$16.9K |
|
136
Philip Morris
PM
$293B
| $18K | 0.01% |
+231
| New | +$19.1K |
|
137
PayPal
PYPL
$49.3B
| $18K | 0.01% |
161
-1,632
| -91% | -$181K |
|
138
Universal Health Services
UHS
$9.08B
| $18K | 0.01% |
+139
| New | +$17.5K |
|
139
AnaptysBio
ANAB
$1.59B
| $17K | 0.01% |
+301
| New | +$21.7K |
|
140
DaVita
DVA
$15.2B
| $17K | 0.01% |
+301
| New | +$15.6K |
|
141
IBM
IBM
$198B
| $17K | 0.01% |
+130
| New | +$17.1K |
|
142
Salesforce
CRM
$139B
| $16K | 0.01% |
104
-681
| -87% | -$107K |
|
|
FOLD
143
DELISTED
Amicus Therapeutics
FOLD
| $16K | 0.01% |
+1,284
| New | +$16.3K |
|
|
AVP
144
DELISTED
Avon Products, Inc.
AVP
| $16K | 0.01% |
4,200
| – | – |
|
145
Coca-Cola Consolidated
COKE
$12.2B
| $15K | 0.01% |
+500
| New | +$15.7K |
|
146
Linde
LIN
$233B
| $15K | 0.01% |
+76
| New | +$14.2K |
|
147
Lockheed Martin
LMT
$117B
| $15K | 0.01% |
+42
| New | +$14.1K |
|
148
Regeneron Pharmaceuticals
REGN
$70.8B
| $15K | 0.01% |
+48
| New | +$16K |
|
149
RTX Corp
RTX
$261B
| $15K | 0.01% |
+178
| New | +$14.9K |
|
|
GBT
150
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15K | 0.01% |
+279
| New | +$16K |
|
Similar funds
MVM
BIP
RA
SCM
PCM
MFWP
FCM
PE
Evolution Wealth Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Evolution Wealth Advisors held 495 positions worth $231M, up 6.4% from $218M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Evolution Wealth Advisors's Q2 2019 filing shows 390 new, 42 increased, 20 reduced and 28 closed positions. Its largest new stake was Bank of America: 714,225 shares worth $27.6M. The largest sale was Vanguard Value ETF, an estimated $11.7M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 4.1% a quarter earlier, followed by Materials and Consumer Discretionary.
- Evolution Wealth Advisors's largest Q2 2019 buy was Bank of America: 714,225 shares worth $27.6M.
- Evolution Wealth Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $7.19M increase.
- Evolution Wealth Advisors's biggest Q2 2019 reduction was Invesco S&P 500 High Dividend Low Volatility ETF, cutting an estimated $684K.
- Evolution Wealth Advisors fully exited Vanguard Value ETF in Q2 2019, selling an estimated $11.7M.
- Evolution Wealth Advisors's ten largest holdings make up 75% of its $231M portfolio in Q2 2019.
- Evolution Wealth Advisors opened 390 new positions and closed 28 in Q2 2019.
- Evolution Wealth Advisors's portfolio value rose 6.4% quarter-over-quarter to $231M.
Based on Evolution Wealth Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.